Chester County News and Community Website
SPRING HOUSE, PA — Johnson & Johnson has submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA), aiming to expand the use of TREMFYA® (guselkumab) …
Johnson & Johnson Seeks FDA Approval to Expand TREMFYA® Use for Pediatric Conditions Read More
EXTON, PA — Lungpacer Medical announced that its AeroPace® System has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA). The approval marks a pivotal moment in …
Lungpacer Medical’s AeroPace System Gains FDA Approval, Transforming Respiratory Care Read More SPRING HOUSE, PA – Johnson & Johnson (NYSE: JNJ) has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval for a subcutaneous (SC) …
Johnson & Johnson Advances Ulcerative Colitis Treatment with FDA Filing for TREMFYA® Subcutaneous Regimen Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received orphan medicinal product designation from the European Medicines Agency (EMA) for OCU410ST, a promising treatment for ABCA4-associated retinopathies including Stargardt disease, …
Ocugen Secures EMA Orphan Designation for OCU410ST, Advancing Stargardt Disease Treatment Read More
WASHINGTON, D.C. — The Federal Trade Commission (FTC) has unveiled its Fiscal Year 2024 Agency Financial Report, showcasing the agency’s achievements in safeguarding consumers and fostering healthy competition. This comprehensive document …
FTC Releases FY 2024 Financial Report: Unbroken Audit Record and Consumer Protection Milestones Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced a groundbreaking approval of Kebilidi (eladocagene exuparvovec-tneq), marking the first gene therapy sanctioned for the treatment of aromatic L-amino …
Revolutionary Gene Therapy Approved: Kebilidi Offers New Hope for Rare Genetic Disorder Read More
WASHINGTON, D.C. — The U.S. Department of Veterans Affairs‘ National Cemetery Administration has awarded $44.5 million in grants aimed at expanding and improving state veterans’ cemeteries. This financial investment for …
VA Allocates $44.5 Million for State Veterans’ Cemetery Enhancements Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved FluMist for self- or caregiver-administration, expanding accessibility for influenza prevention. FluMist, designed to combat influenza virus subtypes A and …
FDA Greenlights FluMist for Self- and Caregiver-Administration Read More
WASHINGTON, D.C. — In a groundbreaking move aimed at enhancing accessibility and innovation in hearing aid technology, the U.S. Food and Drug Administration (FDA) recently authorized the first over-the-counter (OTC) …
Revolutionary Hearing Aid Software Turns AirPods Pro into Accessible Hearing Solutions! Read More HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has announced the FDA‘s approval of TREMFYA® (guselkumab) for adults with moderately to severely active ulcerative colitis (UC). This chronic inflammatory condition affects …
FDA Approves TREMFYA® for Ulcerative Colitis Treatment, Promising New Hope for Patients Read More